United States · FDA National Drug Code directory
Triamterene and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-855_062dc3f3-09ea-4f21-9435-025c4e9d460b
- Product NDC
- 68382-855
- Form
- CAPSULE
- Composition / generic term
- Triamterene and Hydrochlorothiazide
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190331
- Source listing expiry
- 20261231
Source-listed ingredients
- TRIAMTERENE — 37.5 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68382-855-01) · 68382-855-01
- 500 CAPSULE in 1 BOTTLE (68382-855-05) · 68382-855-05
- 1000 CAPSULE in 1 BOTTLE (68382-855-10) · 68382-855-10
- 10 BLISTER PACK in 1 CARTON (68382-855-77) / 10 CAPSULE in 1 BLISTER PACK (68382-855-30) · 68382-855-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →